{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:57:13Z","timestamp":1774274233301,"version":"3.50.1"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Left ventricular noncompaction cardiomyopathy (LVNC) is a distinct form of cardiomyopathy that may present as either an inherited or a sporadic condition. This report describes the first documented case of familial LVNC associated with the\n                    <jats:italic>MYH7<\/jats:italic>\n                    p.Asp461Asn variant. Phenotypic variability among affected individuals within the family was assessed to identify potential contributors to the observed clinical heterogeneity in LVNC. The reported family included 10 individuals across three generations. Two members were diagnosed with LVNC, and 1 was classified as having suspected LVNC. Identical twins (\u2161-1 and \u2161-3) were both found to harbor the heterozygous missense variant c.1381G\u00a0&gt;\u00a0A (p.Asp461Asn) in the\n                    <jats:italic>MYH7<\/jats:italic>\n                    gene. Subsequent pedigree analysis confirmed the presence of this variant in individuals \u2162-1, \u2162-2, and \u2162-4. Clinical observations from this familial case highlight the importance of early identification and intervention in patients with LVNC to mitigate the risks of heart failure, sudden cardiac death, and thromboembolic events. The\n                    <jats:italic>MYH7<\/jats:italic>\n                    variant plays a significant role in the pathogenesis of LVNC and may represent a promising target for future gene-based therapies aimed at improving patient outcomes.\n                  <\/jats:p>","DOI":"10.1515\/biol-2025-1308","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:01:11Z","timestamp":1774270871000},"source":"Crossref","is-referenced-by-count":0,"title":["Familial left ventricular noncompaction cardiomyopathy associated with the p.Asp461Asn\n                    <i>MYH7<\/i>\n                    variant"],"prefix":"10.1515","volume":"21","author":[{"given":"Yanyan","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Geriatrics , Shijiazhuang People\u2019s Hospital , Shijiazhuang , 05000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqi","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics , Shijiazhuang People\u2019s Hospital , Shijiazhuang , 05000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiology , Shijiazhuang People\u2019s Hospital , Shijiazhuang , 05000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Mi","sequence":"additional","affiliation":[{"name":"Department of Cardiology , Shijiazhuang People\u2019s Hospital , Shijiazhuang , 05000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Geriatrics , Shijiazhuang People\u2019s Hospital , Shijiazhuang , 05000 , China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"2026032313010892134_j_biol-2025-1308_ref_001","doi-asserted-by":"crossref","unstructured":"Gao, S, Zhang, S, Wang, Z, Wu, M, Gu, C, Bai, R, et al.. Long-term prognosis of different subtypes of left ventricular noncompaction cardiomyopathy patients: a retrospective study in China. J\u00a0Cardiovasc Dev Dis 2023;10:369. https:\/\/doi.org\/10.3390\/jcdd10090369.","DOI":"10.3390\/jcdd10090369"},{"key":"2026032313010892134_j_biol-2025-1308_ref_002","doi-asserted-by":"crossref","unstructured":"Couissi, A, Obeidat, S, Boutaleb, AM, Habbal, R. Left ventricular noncompaction cardiomyopathy and myocardial bridging association: a coincidence or a usual association? J\u00a0Saudi Heart Assoc 2023;35:254\u20137. https:\/\/doi.org\/10.37616\/2212-5043.1352.","DOI":"10.37616\/2212-5043.1352"},{"key":"2026032313010892134_j_biol-2025-1308_ref_003","doi-asserted-by":"crossref","unstructured":"Tukker, M, Leening, MJG, Mohamedhoesein, S, Vanmaele, ALA, Caliskan, K. Prevalence and clinical correlates of ascending aortic dilatation in patients with noncompaction cardiomyopathy. Int J Cardiovasc Imag 2023;39:1687\u201395. https:\/\/doi.org\/10.1007\/s10554-023-02882-2.","DOI":"10.1007\/s10554-023-02882-2"},{"key":"2026032313010892134_j_biol-2025-1308_ref_004","doi-asserted-by":"crossref","unstructured":"Petersen, SE, Jensen, B, Aung, N, Friedrich, MG, McMahon, CJ, Mohiddin, SA, et al.. Excessive trabeculation of the left ventricle: JACC: cardiovascular imaging expert panel paper. JACC Cardiovasc Imaging 2023;16:408\u201325. https:\/\/doi.org\/10.1016\/j.jcmg.2022.12.026.","DOI":"10.1016\/j.jcmg.2022.12.026"},{"key":"2026032313010892134_j_biol-2025-1308_ref_005","doi-asserted-by":"crossref","unstructured":"McGurk, KA, Zhang, X, Theotokis, P, Thomson, K, Harper, A, Buchan, RJ, et al.. The penetrance of rare variants in cardiomyopathy-associated\u00a0genes: a cross-sectional approach to estimating penetrance for secondary findings. Am J Hum Genet 2023;110:1482\u201395. https:\/\/doi.org\/10.1016\/j.ajhg.2023.08.003.","DOI":"10.1016\/j.ajhg.2023.08.003"},{"key":"2026032313010892134_j_biol-2025-1308_ref_006","unstructured":"Cheng, XQ, Yu, GS. Research progress in isolated left ventricular noncompaction. J\u00a0Pediatr Pharm 2022;28:62\u20135. https:\/\/doi.org\/10.13407\/j.cnki.jpp.1672-108X.2022.03.018."},{"key":"2026032313010892134_j_biol-2025-1308_ref_007","doi-asserted-by":"crossref","unstructured":"Lanza, GA, Bisignani, A, Melita, V, Telesca, A, Tremamunno, S, Cambise, N, et al.. Prognostic assessment of early Repolarization\/J wave electrocardiographic pattern in patients with stable ischemic heart disease. Am J Cardiol 2023;186:236\u201342. https:\/\/doi.org\/10.1016\/j.amjcard.2022.10.008.","DOI":"10.1016\/j.amjcard.2022.10.008"},{"key":"2026032313010892134_j_biol-2025-1308_ref_008","doi-asserted-by":"crossref","unstructured":"Zhou, X, Ren, L, Huang, J, Zhang, Y, Cai, Y, Pu, J. Novel SCN5A frame-shift mutation underlying in patient with idiopathic ventricular fibrillation manifested with J wave in inferior lead and prolonged S-wave in precordial lead. Exp Ther Med 2023;25:287. https:\/\/doi.org\/10.3892\/etm.2023.11986.","DOI":"10.3892\/etm.2023.11986"},{"key":"2026032313010892134_j_biol-2025-1308_ref_009","doi-asserted-by":"crossref","unstructured":"Cuspidi, C, Gherbesi, E, Tadic, M. Left ventricular hypertrophy in hypertension: is the electrocardiogram enough for risk stratification? J\u00a0Clin Hypertens (Greenwich) 2023;25:115\u201316. https:\/\/doi.org\/10.1111\/jch.14614.","DOI":"10.1111\/jch.14614"},{"key":"2026032313010892134_j_biol-2025-1308_ref_010","doi-asserted-by":"crossref","unstructured":"Rickard, J, Jackson, K, Gold, M, Biffi, M, Ziacchi, M, Silverstein, J, et al.. Electrocardiogram belt guidance for left ventricular lead placement and biventricular pacing optimization. Heart Rhythm 2023;20:537\u201344. https:\/\/doi.org\/10.1016\/j.hrthm.2022.11.015.","DOI":"10.1016\/j.hrthm.2022.11.015"},{"key":"2026032313010892134_j_biol-2025-1308_ref_011","doi-asserted-by":"crossref","unstructured":"Naderi, H, Ram\u00edrez, J, van Duijvenboden, S, Pujadas, ER, Aung, N, Wang, L, et al.. Predicting left ventricular hypertrophy from the 12-lead electrocardiogram in the UK biobank imaging study using machine learning. Eur Heart J Digit Health 2023;4:316\u201324. https:\/\/doi.org\/10.1093\/ehjdh\/ztad037.","DOI":"10.1093\/ehjdh\/ztad037"},{"key":"2026032313010892134_j_biol-2025-1308_ref_012","doi-asserted-by":"crossref","unstructured":"McDonagh, TA, Metra, M, Adamo, M, Gardner, RS, Baumbach, A, B\u00f6hm, M, et al.. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44:3627-39. https:\/\/doi.org\/10.1093\/eurheartj\/ehad195.","DOI":"10.1093\/eurheartj\/ehad195"},{"key":"2026032313010892134_j_biol-2025-1308_ref_013","doi-asserted-by":"crossref","unstructured":"Arbelo, E, Protonotarios, A, Gimeno, JR, Arbustini, E, Barriales-Villa, R, Basso, C, et al.. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 2023;44:3503\u2013626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194.","DOI":"10.1093\/eurheartj\/ehad194"}],"container-title":["Open Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1308\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1308\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:01:14Z","timestamp":1774270874000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/biol-2025-1308\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,20]]},"published-print":{"date-parts":[[2026,1,23]]}},"alternative-id":["10.1515\/biol-2025-1308"],"URL":"https:\/\/doi.org\/10.1515\/biol-2025-1308","relation":{},"ISSN":["2391-5412"],"issn-type":[{"value":"2391-5412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"20251308"}}